BackGenerate Biomedicines Overview

Generate Biomedicines Long Term Debt

Generate Biomedicines's long-term debt is $49M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$49.01M

Peer trimmed avg / median

Loading

Generate Biomedicines Long Term Debt History

Loading

Generate Biomedicines vs. peers: Long Term Debt Comparison

Loading

Generate Biomedicines Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Generate Biomedicines (GENB) FAQ

Generate Biomedicines (GENB) currently reports a long-term debt of $49M as of June 2026. Use the charts on this page to explore Generate Biomedicines's long-term debt history and peer comparisons.

Generate Biomedicines reported $49M in long-term debt as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $49M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Generate Biomedicines, and consider following GENB for alerts when major investors trade the stock.